Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II randomized double-blind trial of an adsorbed acellular DTaP-Sabin IPV combination vaccine in infants and children
CTR20263773Phase 2Active
- Sponsor
- Institute of Medical Biology Chinese Academy of Medical Sciences
- Start
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of adsorbed acellular DTaP-Sabin IPV combination vaccine in pertussis, diphtheria, Tetanus, poliomyelitis, sponsored by Institute of Medical Biology Chinese Academy of Medical Sciences. Started Oct 2026; status: active.
02
Drugs
adsorbed acellular DTaP-Sabin IPV combination vaccine
03
Conditions
pertussisdiphtheriaTetanuspoliomyelitis
Beyond the preview
Go deeper on CTR20263773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263773.